Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
Clinical trial NCT01374516 · COMPLETED
Trial details
- NCT number
- NCT01374516
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-08
- Primary completion
- 2014-11-01
- Enrollment
- 20869
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.